导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.88% | 2264/3406 |
| 近一周 | -1.74% | 1834/4642 |
| 近一月 | -2.84% | 2234/4620 |
| 近一季 | -1.03% | 2377/4441 |
| 近半年 | 16.96% | 2124/3981 |
| 近一年 | 15.94% | 2134/3342 |
| 近两年 | 33.92% | 1436/2453 |
| 近三年 | 14.43% | 1367/1947 |
| 成立以来 | 68.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.87% 2440/3635 |
1.79% 2137/4076 |
18.24% 2325/4523 |
- - |
| 2024 | 13.31% 1154/3464 |
1.99% 835/2808 |
-1.72% 1100/3014 |
16.12% 1530/3130 |
-2.65% 2151/3464 |
| 2023 | -11.05% 1364/2655 |
3.50% 1180/2280 |
-5.00% 1338/2385 |
-3.54% 949/2515 |
-6.21% 1671/2655 |
| 2022 | -20.29% 958/2208 |
-14.50% 954/1919 |
6.98% 559/2016 |
-13.04% 825/2113 |
0.21% 1524/2208 |
| 2021 | 1.26% 682/1822 |
-2.63% 683/1255 |
7.93% 660/1330 |
-5.47% 811/1466 |
1.93% 746/1822 |
| 2020 | 35.55% 408/1246 |
-6.19% 465/1028 |
15.47% 498/1067 |
10.58% 533/1164 |
13.16% 385/1184 |
| 2019 | 31.26% 474/1092 |
25.13% 478/754 |
-3.68% 406/804 |
4.77% 183/850 |
3.94% 822/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 前海开源MSCI中国A股指数A VS. () |